accepted manuscript

More documents

Recommendations

Info

81. ACCEPTED MANUSCRIPT [55] A.M. Penn, T. Roberts, J. Hodder, P.S. Allen, G. Zhu, W.R. Martin, Generalized mitochondrial dysfunction in Parkinson's disease detected by magnetic resonance spectroscopy of muscle, Neurology 45 (1995) 2097-2099. [56] J.M. Shoffner, R.L. Watts, J.L. Juncos, A. Torroni, D.C. Wallace, Mitochondrial oxidative phosphorylation defects in Parkinson's disease, Annals of neurology 30 (1991) 332-339. [57] A.H. Schapira, V.M. Mann, J.M. Cooper, D. Dexter, S.E. Daniel, P. Jenner, J.B. Clark, C.D. Marsden, Anatomic and disease specificity of NADH CoQ1 reductase (complex I) deficiency in Parkinson's disease, Journal of neurochemistry 55 (1990) 2142-2145. [58] W.D. Parker, Jr., J.K. Parks, R.H. Swerdlow, Complex I deficiency in Parkinson's disease frontal cortex, Brain research 1189 (2008) 215-218. [59] P.M. Keeney, J. Xie, R.A. Capaldi, J.P. Bennett, Jr., Parkinson's disease brain mitochondrial complex I has oxidatively damaged subunits and is functionally impaired and misassembled, J Neurosci 26 (2006) 5256-5264. [60] U. Brandt, Energy converting NADH:quinone oxidoreductase (complex I), ACCEPTED MANUSCRIPT Annual review of biochemistry 75 (2006) 69-92. [61] S. Papa, D. De Rasmo, S. Scacco, A. Signorile, Z. Technikova-Dobrova, G. Palmisano, A.M. Sardanelli, F. Papa, D. Panelli, R. Scaringi, A. Santeramo, Mammalian complex I: a regulable and vulnerable pacemaker in mitochondrial respiratory function, Biochimica et biophysica acta 1777 (2008) 719-728. [62] M. Klingenberg, W. Slenczka, [Pyridine nucleotide in liver mitochondria. An analysis of their redox relationships.], Biochemische Zeitschrift 331 (1959) 47
486-517. ACCEPTED MANUSCRIPT [63] B. Chance, G. Hollunger, Energy-linked reduction of mitochondrial pyridine nucleotide, Nature 185 (1960) 666-672. [64] M.P. Murphy, How mitochondria produce reactive oxygen species, The Biochemical journal 417 (2009) 1-13. [65] A.Y. Andreyev, Y.E. Kushnareva, A.A. Starkov, Mitochondrial metabolism of reactive oxygen species, Biochemistry (Mosc) 70 (2005) 200-214. [66] A.A. Starkov, The role of mitochondria in reactive oxygen species metabolism and signaling, Annals of the New York Academy of Sciences 1147 (2008) 37- 52. [67] A.J. Lambert, M.D. Brand, Reactive oxygen species production by mitochondria, Methods in molecular biology (Clifton, N.J 554 (2009) 165- 181. [68] D. Harman, The biologic clock: the mitochondria?, Journal of the American Geriatrics Society 20 (1972) 145-147. [69] A.W. Linnane, S. Marzuki, T. Ozawa, M. Tanaka, Mitochondrial DNA mutations as an important contributor to ageing and degenerative diseases, ACCEPTED MANUSCRIPT Lancet 1 (1989) 642-645. [70] A. Trifunovic, N.G. Larsson, Mitochondrial dysfunction as a cause of ageing, Journal of internal medicine 263 (2008) 167-178. [71] K. Khrapko, J. Vijg, Mitochondrial DNA mutations and aging: devils in the details?, Trends Genet 25 (2009) 91-98. [72] R. Fato, C. Bergamini, M. Bortolus, A.L. Maniero, S. Leoni, T. Ohnishi, G. Lenaz, Differential effects of mitochondrial Complex I inhibitors on production of reactive oxygen species, Biochimica et biophysica acta 1787 48
Page 1 and 2: ÔØ ÅÒÙ× ÖÔØ Mitochondrial
Page 3 and 4: Abstract ACCEPTED MANUSCRIPT Mitoch
Page 5 and 6: ACCEPTED MANUSCRIPT function mechan
Page 7 and 8: ACCEPTED MANUSCRIPT high lipophilic
Page 9 and 10: ACCEPTED MANUSCRIPT transfer from N
Page 11 and 12: ACCEPTED MANUSCRIPT force (ΔpH and
Page 13 and 14: ACCEPTED MANUSCRIPT about 1500 diff
Page 15 and 16: ACCEPTED MANUSCRIPT mtDNA point mut
Page 17 and 18: ACCEPTED MANUSCRIPT increases the v
Page 19 and 20: 2.1.2. PINK1 substrates ACCEPTED MA
Page 21 and 22: 2.2. Parkin ACCEPTED MANUSCRIPT 2.2
Page 23 and 24: ACCEPTED MANUSCRIPT Remarkably, LaV
Page 25 and 26: ACCEPTED MANUSCRIPT [204]. None of
Page 27 and 28: ACCEPTED MANUSCRIPT 218] (see Fig.
Page 29 and 30: ACCEPTED MANUSCRIPT strategies migh
Page 31 and 32: ACCEPTED MANUSCRIPT autophagy in PI
Page 33 and 34: 2.3. DJ-1 ACCEPTED MANUSCRIPT Mutat
Page 35 and 36: ACCEPTED MANUSCRIPT Similarly to ot
Page 37 and 38: ACCEPTED MANUSCRIPT 2527 amino acid
Page 39 and 40: Acknowledgements ACCEPTED MANUSCRIP
Page 41 and 42: References ACCEPTED MANUSCRIPT [1]
Page 43 and 44: ACCEPTED MANUSCRIPT Sciences of the
Page 45 and 46: ACCEPTED MANUSCRIPT biological chem
Page 47: ACCEPTED MANUSCRIPT [47] B. Janetzk
Page 51 and 52: ACCEPTED MANUSCRIPT Parkinson's dis
Page 53 and 54: ACCEPTED MANUSCRIPT variants in idi
Page 55 and 56: ACCEPTED MANUSCRIPT causes of Parki
Page 57 and 58: ACCEPTED MANUSCRIPT [125] A. Grunew
Page 59 and 60: ACCEPTED MANUSCRIPT [136] G.B. John
Page 61 and 62: ACCEPTED MANUSCRIPT maturation or s
Page 63 and 64: ACCEPTED MANUSCRIPT [163] C. Hampe,
Page 65 and 66: 114-122. ACCEPTED MANUSCRIPT [179]
Page 67 and 68: ACCEPTED MANUSCRIPT (2004) 1328-133
Page 69 and 70: ACCEPTED MANUSCRIPT Dalkara, N. Oze
Page 71 and 72: ACCEPTED MANUSCRIPT [217] H. Deng,
Page 73 and 74: ACCEPTED MANUSCRIPT dispensable for
Page 75 and 76: 35 (2001) 301-310. ACCEPTED MANUSCR
Page 77 and 78: ACCEPTED MANUSCRIPT multiplications
Page 79 and 80: ACCEPTED MANUSCRIPT [270] A.M. Cuer
Page 81 and 82: ACCEPTED MANUSCRIPT Neuroscience le
Page 83 and 84: ACCEPTED MANUSCRIPT Ferrante, N.W.
Page 85 and 86: ACCEPTED MANUSCRIPT Meitinger, W. K
Page 87 and 88: ACCEPTED MANUSCRIPT ACCEPTED MANUSC
Page 89: ACCEPTED MANUSCRIPT ACCEPTED MANUSC

accepted manuscript

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?